Maria Stamou is an Endocrinology/Metabolic physician affiliated with Massachusetts General Hospital. OpenAlex indexes 88 publications with 980 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
100%GLP-1 receptor agonist100%Trulicity100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2022–2026 per NIH RePORTER. The latest:
- Elucidating the Role of the FGFR1 Signaling Pathway in the Intersection of Reproduction and Metabolism
Massachusetts General Hospital
FY2026$170,640K23HD117006 - Elucidating the Role of the FGFR1 Signaling Pathway in the Intersection of Reproduction and Metabolism
Massachusetts General Hospital
FY2025$170,640K23HD117006 - Deciphering the Role of Copy Number Variants in Neuroendocrine Disorders of Infertility
Massachusetts General Hospital
FY2024$84,064F32HD108873
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Reversal of Congenital Hypogonadotropic Hypogonadism
The Journal of Clinical Endocrinology & Metabolism
2025 - Defective FGFR1 Signaling Disrupts Glucose Regulation: Evidence From Humans With <i>FGFR1</i> Mutations
Journal of the Endocrine Society
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Januzzi, MD
Massachusetts General Hospital
Maurizio Fava, MD
Massachusetts General Hospital
Steven Greenberg, MD
Massachusetts General Hospital
David Scadden, MD
Massachusetts General Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”